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ABSTRACT
Background. Electrophysiological endophenotypes are far less explored in bipolar disorder as
compared to schizophrenia. No previous twin study of event-related potentials (ERPs) in bipolar
illness has been reported. This study uses a twin design and advanced genetic model fitting analyses
aiming to (1) assess and quantify the relationship of a range of ERP components with bipolar
disorder with psychotic features, and (2) examine the source of the relationship (due to genetic or
environmental factors).
Method. P300, P50 suppression and mismatch negativity (MMN) were recorded in 10 discordant
monozygotic (MZ) bipolar twin pairs, six concordant MZ bipolar twin pairs and 78 control twin
pairs. Statistical analyses were based on structural equation modelling.
Results. Bipolar disorder was significantly associated with smaller P300 amplitude and decreased
P50 suppression. Genetic correlations were the main source of the associations, estimated to be
x0.33 for P300 amplitude and 0.46 for P50 ratio. Individual-specific environmental influences were
not significant. MMN and P300 latency were not associated with the illness.
Conclusions. The results provide supporting evidence that P300 amplitude and P50 suppression
ratio are ERP endophenotypes for bipolar disorder.
INTRODUCTION
Bipolar disorder is a highly heritable, chronic
and disabling illness and has a complex aeti-
ology (Shastry, 2005). No genes for bipolar dis-
order have been identified definitively, although
there are many promising candidates (Levinson
et al. 2003; DePaulo, 2004; Craddock et al.
2005; Green et al. 2005; McQueen et al. 2005;
Raybould et al. 2005). Attempts have been made
to find endophenotypes that can reduce the
phenotypic complexity of bipolar disorder,
improve the power in identification of possible
gene carriers, and help to clarify the biological
and genetic basis of the disorder (Lenox et al.
2002; Hasler et al. 2006).
The event-related potential (ERP) com-
ponents, P50 suppression, P300 amplitude and
latency, and mismatch negativity (MMN) have
been proposed as potential endophenotypes for
schizophrenia on the basis of family studies
(Jeon & Polich, 2001, 2003; Bramon et al. 2004;
Umbricht & Krljes, 2005). Few studies, how-
ever, have investigated these ERPs in patients
with bipolar disorder. In addition, the potential
of using the ERP measures as endophenotypes
for bipolar disorder is far less explored than
for schizophrenia. Of the ERP studies reported,
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bipolar patients show some similar impairments
with schizophrenic patients, but results are far
from conclusive.
One study observed both reduced P300
amplitude and prolonged latency in bipolar
patients (Muir et al. 1991), one reported ampli-
tude reductions (Salisbury et al. 1999), and one
latency delays (Souza et al. 1995). There are two
family reports, one demonstrating both reduced
P300 amplitude and prolonged latency in rela-
tives (Pierson et al. 2000) and the other finding
prolonged latency in relatives (Schulze et al.
2005).
As for P50 suppression, earlier studies sug-
gested that abnormal P50 suppression in patients
may be state dependent (Franks et al. 1983;
Adler et al. 1990; Baker et al. 1990). However,
these studies included both psychotic and non-
psychotic bipolar patients. A recent study found
that psychotic bipolar patients showed impair-
ment of P50 suppression, similar to patients with
diagnosis of schizo-affective disorder, bipolar
type, and schizophrenia, while non-psychotic
bipolar patients have normal P50 suppression
(Olincy & Martin, 2005). Our group has inves-
tigated P50 suppression in relatives of bipolar
patients and found impairment in both patients
and relatives, suggesting that P50 suppression
may be associated with genetic liability to psy-
chotic bipolar illness (Schulze et al. 2006).
Deficits in MMN have not been observed in
bipolar patients (Catts et al. 1995; Umbricht
et al. 2003). Both Catts et al. (1995) and
Umbricht et al. (2003) have found that, while
MMN amplitude is clearly reduced in schizo-
phrenic patients, it is normal in bipolar patients.
A preliminary family study of bipolar disorder
reported no evidence of MMN deficits in unaf-
fected relatives (Schulze, personal communi-
cation). These results suggest that MMN deficits
may be fairly specific to schizophrenia.
The classical twin design compares the differ-
ence in phenotypic similarity between mono-
zygotic (MZ) twins and dizygotic (DZ) twins
to untangle the effects of genes from the effects
of family environment on any trait (Neale
& Cardon, 1992; Kendler, 2001; Rijsdijk &
Sham, 2002). In addition, the twin design,
when augmented by sophisticated structural
equation modelling techniques, is able to exam-
ine the extent of genetic overlap between two
traits, such as a disease and its putative
endophenotype (Neale & Kendler, 1995;
Boomsma et al. 2002; Rijsdijk & Sham, 2002;
Cannon, 2005; Koenen et al. 2005). Under-
standing the extent of genetic overlap may be
crucial, because a significant genetic association
validates the proposed phenotypic measure as an
endophenotype for the disorder andmay be used
in linkage and association analyses (Allison et al.
1998; Lenox et al. 2002; Gottesman & Gould,
2003).
There is, to our knowledge, no twin study of
ERP in bipolar illness. The present study is the
first to use a twin design and advanced genetic
model fitting analyses aiming to (1) assess
and quantify the relationship of each ERP
component with bipolar disorder with psychotic
features, and (2) examine the source of the
relationship (due to genetic or environmental
factors). Based on the literature findings re-
viewed above, we predicted that (a) bipolar
affected individuals would show deficits on the
P300 and P50 measures, but normal MMN, and
(b) bipolar disorder would be associated with
P300 and P50 suppression but not MMN.
METHOD
Sample
The study was approved by the UK Multi-
centre Research Ethics Committee. Probands
were referred from across the UK by their
treating psychiatrist or recruited from national
media advertisements for the Maudsley Twin
Study of bipolar disorder. Another source was
by advertisement in the Manic Depressive
Fellowship. Control twins were recruited from
the Institute of Psychiatry Volunteer Twin
Register and through advertisements. Written
informed consent was obtained from all parti-
cipants after a detailed description of the study
aims and design.
The sample consisted of 10 MZ twin pairs
discordant for bipolar disorder [mean age (S.D.)
41.8 (13.7) years], six MZ twin pairs concordant
for bipolar disorder [mean age (S.D.) 40.3 (14.5)
years] and 78 control twin pairs : 46 MZ [mean
age (S.D.) 33.3 (10.3) years] and 32 DZ twin pairs
[mean age (S.D.) 40.2 (12.6) years]. Of those
control twin pairs, 19 MZ pairs (eight male, 11
female, mean age 36.76 years) were tested on
two occasions with an average inter-test interval
of 17.8 days (range 7–56 days), so that the
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measurement error of each ERP component
could be estimated.
Clinical assessment
All subjects underwent the same extensive clini-
cal assessment. Diagnoses were based on all
available clinical information concerning each
twin, including structured clinical interviews
using the Schedule for Clinical Assessment in
Neuropsychiatry (version 2.1) or the Structured
Clinical Interview for DSM-IV (SCID; First
et al. 1997). Exclusion criteria applied to all
groups included a history of neurological dis-
order, hearing impairment, a history of head
trauma resulting in loss of consciousness of more
than 10 min, and current substance dependence.
Data on medication history were collected at the
time of assessment. The probability that any of
the discordant twins would become concordant
in the future was low, as an average of 21.2 years
(S.D.=11.28) had elapsed since the onset of
the probands’ illness (Belmaker et al. 1974). All
patients met DSM-IV diagnosis for bipolar I
disorder, except one who was diagnosed with
schizo-affective, bipolar type, disorder. All
patients except one (95%) had a history of
psychotic symptoms some time in their life.
Control subjects had no personal or family
history of any psychotic or bipolar disorder.
Eleven of the patients were taking anti-
psychotic in combination with mood stabilizer
and/or antidepressants, three were taking anti-
depressant medications in combination with
mood stabilizers, two were taking mood stabil-
izers only and one was taking antidepressants
only. The remaining five patients were not cur-
rently receiving any psychiatric medication. Six
had a history of alcohol dependence and one
member of a concordant twin pair met criteria
for current alcohol abuse. Three had a history
of drug abuse and one with dependence. All
patients were clinically stable at the time of
assessment with no recent changes to their
medication.
Four non-bipolar co-twins from the discor-
dant groups and 19 controls had a history of
DSM-IV diagnosis of major depression. One
non-bipolar co-twin and six controls had a his-
tory of anxiety disorder. None were taking
psychotropic medications at the time of study,
with exception of one co-twin who was taking
a low dosage of amitriptyline 20–30 mg daily.
Zygosity was determined using 12 highly poly-
morphic DNA markers and a standardized twin
likeness questionnaire.
Study design
The study design was based on power analyses
that used simulated data to estimate the number
of twin pairs required to detect different levels of
heritability of the ERPs and their genetic corre-
lation with bipolar disorder under a range
of assumptions. The power of this design was
sufficient to detect a heritability of 60% for an
ERP component and, at this heritability, a gen-
etic correlation of 0.40 between the ERP and
bipolar disorder (data available upon request).
Procedure and tasks
Three separate recordings, P50, MMN and
P300, were carried out in a fixed order using a
methodology described in detail elsewhere (Hall
et al. 2006). In brief, data were collected using
Neuroscan software. Electroencephalogram
(EEG) data were recorded according to the
10/20 International System (Jasper, 1958), ref-
erenced to the left ear. Eye movements were
recorded from the outer canthus of each eye,
above and below the left eye. Electrode im-
pedances were below 6 kV. EEG activity was
amplified 1000 times with 0.03 high-pass and
120 low-pass filters, and digitized at a 500 Hz
rate. Subjects had last smoked a minimum
of 40 min before data collection (Adler et al.
1993).
P300
P300 was assessed using an auditory oddball
paradigm [400 binaural 80 dB, 20 ms stimuli,
20% target (1500 Hz) and 80% standard
(1000 Hz) tones]. Participants pressed a button
in response to a target tone. EEG data were
epoched (x100 to 800 ms), digitally filtered
(0.15–40 Hz), low-pass filtered (8.5 Hz) and
baseline corrected. Eye-blink artefacts were
corrected using regression based weighting
coefficients (Semlitsch et al. 1986). Epochs were
rejected if amplitudes exceeded 50 mV in F7, F8,
Fp1 or Fp2 and if residual horizontal eye
movements were present in thex100 to 800 ms
period. Separate average waves for target and
standard tones were calculated and measured at
PZ between 280 and 600 ms.
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MMN
MMN was elicited by a duration auditory odd-
ball task using four blocks of 400 binaural 80 dB
stimuli (ISI: 0.3 s) with 85% standards (25 ms,
1000 Hz, 5 ms rise/fall time) and 15% deviants
(50 ms). EEG data were epoched (x100 to
300 ms), filtered (0.1–30 Hz) and baseline
corrected. Epochs were rejected if amplitudes
exceeded 100 mV in any channel. Eyeblink
artefacts were corrected as above. MMN was
extracted by subtracting standard from deviant
averaged waveforms. MMN amplitude was
measured at FZ between 50 and 200 ms.
P50 suppression
P50 waves were recorded with a conditioning-
testing paradigm separated by 500-ms and 10-s
inter-trial intervals. Participants were presented
with four or five blocks of 30 conditioning
(C)–test (T) click pairs. Blocks were separated
by 1-min breaks. Stimulus intensity was ad-
justed individually to 43 dB above hearing
threshold. EEG signals were epoched (x100 to
400 ms), filtered (1 Hz high pass) and baseline
corrected. Epochs with activity exceeding
20 mV in the CZ or EOG channel between
0 and 75 ms post-stimulus were automatically
rejected. Epochs were averaged separately for
the condition and test waveforms, digitally fil-
tered (10 Hz high pass) and smoothed (7-point
twice). P50 ERPs were reported at CZ. For the
conditioning response, the most prominent peak
40–75 ms post-stimulus was selected as the P50
peak. The preceding negative trough was used
to calculate the amplitude. For the test response,
the positive peak with latency closest to that of
the conditioning P50 peak was selected as the
test response and its amplitude determined as
for the conditioning wave. P50 suppression ratio
was calculated as (T/C)r100.
Statistical analyses
Comparison of means
For each ERP measure, we compared the means
of the following groups: MZ concordant for
bipolar disorder, MZ discordant affected, MZ
discordant unaffected, and healthy control
twins. An observed ERP impairment in the un-
affected MZ discordant twins similar to that of
their affected co-twins would suggest a genetic
effect, whereas values intermediate between
patients and healthy controls would indicate
that deficits are caused by illness progression as
well as the genetic predisposition.
Mean comparisons were analysed using the
regression command in STATA (Stata Corpor-
ation, College Station, TX, USA), which allows
for non-independent observations (i.e. twin
pairs) by using a robust sandwich estimator to
estimate standard errors. Gender and age were
included as covariates. Linear or logistic (for
categorical variables) regression analyses were
applied to assess overall group differences in
demographic variables. A simple t test was used
for assessing differences in age at onset between
groups.
Structural equation modelling
A more sophisticated approach to the analysis
of twin data is by using structural equation
models, which aim to explain the pattern of
correlations between variableswithin individuals
and across twins by a linear model of relation-
ships between latent and observed variables
(Boomsma et al. 2002; Rijsdijk & Sham, 2002;
Posthuma et al. 2003; Cannon, 2005; Koenen et
al. 2005). Twin modelling was performed using
the Mx statistical program (Neale et al. 1999).
Twin correlations and genetic analysis were
based on sex- and age-regressed residuals.
For the present study, however, model fitting
was complicated by a number of factors : (a)
the multivariate nature of the data, involving
bipolar disorder and multiple ERP measures,
(b) repeated measurements for the MZ control
twin group, (c) the dichotomous nature of bi-
polar disorder, and (d) the uncertain ascertain-
ment process for MZ twins concordant and
discordant for bipolar disorder. We used four
analytical strategies to overcome each of these
difficulties :
(a) We used multivariate models that con-
sider the patterns of covariances between mul-
tiple variables both within individuals and across
twins (Baare et al. 2001). We also considered
each of the ERP paradigms separately in the
model fitting analyses as we found no evidence
of a genetic overlap between these paradigms
(Hall et al. 2006).
(b) We included additional observed vari-
ables in the covariance model for the MZ con-
trol pairs that were retested. For example, for
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the P300 paradigm, each MZ twin member had
five variables in the data, while each DZ twin
member had three variables.
(c) We used liability-threshold models for
both bipolar disorder and ERP variables
(Falconer & Mackay, 1996). The liability-
threshold models for the dichotomized bipolar
phenotype (affected versus non-affected) assume
that risk is normally distributed on a continuum
and that the disorder occurs only when
a certain threshold is exceeded (Neale &
Kendler, 1995). As the Mx software used did
not allow simultaneous analyses of dichot-
omized and continuous data, we modelled both
bipolar disorder and ERP as threshold traits.
Data from each ERP variable were recoded into
seven equal ordinal classes that should capture
most of the information in the continuous data.
(d) We fixed the genetic model parameters for
bipolar disorder to values supported by studies
in the literature (Rijsdijk et al. 2005). We based
values on the report of McGuffin et al. (2003),
which includes the largest affected twin pair
sample ascertained so far, as no published meta-
analysis is available to date. We use three dif-
ferent sets of values for the bipolar parameters :
the point estimates (model 2: h2=0.85, c2=0,
e2=0.15), the lower (model 3: h2=0.73, c2=0,
e2=0.27) and upper 95% confidence interval
(CI) (model 1: h2=0.93, c2=0, e2=0.07). In
addition, we fixed the bipolar prevalence rate to
a lifetime risk of 1%.
Twin correlations
Twin correlations between the ERP measures
and bipolar disorder were estimated by fitting a
correlation matrix to the corresponding ob-
served MZ/DZ raw data. The correlation matrix
for each ERP variable was constrained to pro-
duce (i) the same cross-trait within-twin corre-
lation regardless of zygosity, twin order and
occasion; (ii) the same MZ cross-twin within-
trait correlation regardless of occasion; (iii) the
same MZ cross-twin cross-trait correlation re-
gardless of twin order and occasion; and (iv) the
same DZ cross-twin cross-trait correlation re-
gardless of twin order.
Genetic model fitting
Genetic model fitting was applied to estimate (1)
the heritability of each ERP variable, (2) genetic
and environmental correlations of bipolar dis-
order with each ERP index, and (3) the measure-
ment errors of each ERP index. The applied full
ACEM bivariate liability-threshold model (for
both P50 and MMN paradigms) is illustrated in
Fig. 1. The liability-threshold model for bipolar
and the P300 paradigm was analysed in a similar
way, except that the model included both the
amplitude and latency. The source of the pheno-
typic correlations is derived from comparing the
correlation between one twin’s bipolar liability
and the co-twin’s ERP score. Significantly
greater MZ cross-trait cross-twin correlations
compared to the DZ correlations suggest that
genetic effects contribute to the bipolar–ERP
association. The genetic correlation (rg) in-
dicates the extent to which genetic factors on
bipolar disorder are the same as those on the
ERP component.
Models were fitted directly to raw data. A
goodness-of-fit index (x2) was obtained by
computing the difference in likelihoods (and
degrees of freedom) between the genetic models
and the correlational model. Submodels of the
full ACEMmodel were evaluated by comparing
the difference in x2 relative to the difference in
degrees of freedom, according to principals of
parsimony, operationalized by the significance
of the difference in x2.
RESULTS
Subject
The demographic characteristics of the partici-
pants are given in Table 1. Groups did not differ
in age, sex or years of education. However,
controlling for age and sex, there were signifi-
cant differences in parental socio-economic
status (SES), the proportion of current regular
smokers and the number of cigarettes smoked
per day between groups. Parental SES was sig-
nificantly lower for the concordant twin pairs
than other twin groups, who did not differ from
each other. The proportions of current regular
smokers were significantly higher in patients of
the concordant twins versus control [odds ratio
(OR) 6.5, 95% CI 1.80–23.65] and in patients of
discordant twins versus control (OR 7.9, 95%
CI 1.96–31.50). In addition, among smokers,
patients in the concordant twin group smoked
significantly more cigarettes per day (estimated
difference 10.4, 95% CI 2.81–18.05) than the
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other three groups, who did not differ from each
other.
Comparison of means
Apart from one possible outlier (a P300 latency
score of a discordant co-twin member), no ex-
treme scores were observed in any of the ERP
variables.Whenwe repeated the analyses of P300
latency excluding this possible outlier, results of
both mean and genetic analyses remained essen-
tially unchanged (details available from authors
on request). We therefore reported results from
the original analyses.
As predicted, there was no mean difference in
MMN between the bipolar groups and the con-
trols (Table 2). Bipolar patients from concord-
ant twin pairs had reduced P300 amplitude,
delayed P300 latency, and abnormal P50 sup-
pression ratio, all significant compared to con-
trols. Bipolar patients and their co-twins from
discordant twin pairs also had lower P300 am-
plitude and prolonged latency compared to
Table 1. Demographic characteristics of each twin group
Characteristic
BP CC ill
(n=12)
BP DC ill
(n=10)
BP DC well
(n=10)
Controls
(n=154) Statistics p value
Age, mean (S.D.), years 40.3 (14.5) 41.8 (13.7) 41.8 (13.7) 36.03 (11.75) F=1.07 0.35
Age at onset, mean (S.D.), years 20 (4.2) 20.6 (5.4) N.A. N.A. t=x0.29 0.77
Female sex, n (%) 6 (50) 8 (80) 8 (80) 120 (75) x2=4.09 0.25
Education, mean (S.D.), years 13.4 (3.8) 15.7 (2.4) 15 (2.9) 14.7 (2.23) F=1.76 0.16
Parental SES, mean (S.D.) 3.7 (0.5) 2.6 (0.8) 2.6 (0.8) 2.9 (0.9) F=3.77 0.01
Current smoker, n (%) 6 (50) 5 (50) 1 (10) 25 (16) x2=15.27 0.002
No. cigarettes per day,
if smoker
19.8 (12.5) 11.4 (12.0) 15 9.5 (5.8) F=2.68 0.06
BP, Bipolar disorder; CC ill, concordant affected; DC ill, discordant affected; DC well, discordant unaffected; S.D., standard deviation;
N.A., not applicable ; SES, socio-economic status, based on details of parental occupation at birth of the participant, derived from Office of
Population Censuses and Surveys Standard Occupational Classification (1 indicates highest, 5 lowest).
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FIG. 1. Example of a path diagram of the ACEM genetic model for bipolar disorder and an event-related potential (ERP)
measure [e.g. P50 ratio or mismatch negativity (MMN) amplitude] for monozygotic (MZ) pairs. ERP1 and ERP2, ERP measure-
ments on occasions 1 and 2 respectively; A, additive genetic effects ; C, common environment ; E, specific environment ; M,
measurement error. In the model, two common factors (genetic A1 and specific environmental E1 effects) influence both bipolar
(path coefficients a1 and e1) and ERP variables (path coefficients ak1 and ek1). A2, C2, E2 and M2 are factors that influence only ERP
(path coefficients a2, c2, e2, m2). Parameters for the bipolar disorder (heritability, shared and specific environmental estimates) are
fixed values according to McGuffin et al. (2003). Parameters of bipolar familial environmental effect and its correlation with ERP
measure were constrained to be 0.
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controls, but these differences did not reach sig-
nificance. Contrary to our prediction, patients
of discordant twin pairs had mean P50 sup-
pression similar to that of controls. Significant
mean differences between patients of concord-
ant twin pairs and those of discordant twins
were found for the P300 amplitude (p=0.03),
latency (p=0.04) and P50 ratio (p=0.04).
Patients of discordant twins did not differ sig-
nificantly from their well co-twins for any of the
measures.
Relationship between bipolar and MMN
amplitude
The full genetic ACEM model for each ERP
paradigm fitted the data well (MMN p=0.73;
P50 p=0.18; P300 p=0.06). Table 3 shows
maximum likelihood estimates of twin corre-
lations. Genetic model fitting results are pres-
ented in Tables 4 and 5.
MZ within-trait cross-twin correlation was
greater than the DZ, suggesting a genetic
contribution to MMN (Table 3). Significant
heritability (h2=0.55, 95% CI 0.01–0.71) was
found in model 1 with no shared environmental
influences (c2=0.01). Significant individual
specific-environmental effects were also found
(e2=0.27, 95% CI 0.09–0.49) across all three
models (Table 4).
MMN amplitude was not associated with
bipolar disorder. The phenotypic correlation
(rph) was not significant (p=0.13) and could be
dropped from the model, suggesting no overlap
between the two traits (Table 5).
Relationship between bipolar and P50
suppression
Substantial heritability (h2=0.56–0.57, 95% CI
0.26–0.72) and significant individual specific-
environmental influences (e2=0.24, 95% CI
0.05–0.46) were found (Table 4). Measurement
error was estimated at around 0.20.
A significant phenotypic correlation of bipolar
disorder with P50 suppression ratio was found
across all three models (rph=0.23–0.26, 95% CI
0.04–0.43, Table 5), such that bipolar disorder
Table 2. Summary statistics of ERP indices and results of mean group comparisons (standard
deviations)
BP CC ill
(n=12)
BP DC ill
(n=10)
BP DC well
(n=10)
Control twins
(n=154)
BP CC ill
versus control
BP DC ill
versus control
BP DC well
versus control
t p t p t p
MMN amplitude (mV) x2.98 (2.00) x3.30 (1.01) x2.73 (1.16) x3.38 (1.46) 0.64 0.52 x0.45 0.66 0.98 0.33
P50 ratio (%) 69.12 (40.39) 35.60 (24.67) 48.06 (27.55) 33.67 (24.64)* 2.44 0.02 0.27 0.79 1.65 0.10
P300 amplitude (mV) 8.80 (2.69) 13.61 (6.44) 15.30 (7.07) 16.82 (5.45)* x5.87 <0.0001 x1.46 0.15 x0.54 0.59
P300 latency (ms) 378.17 (39.72) 353.80 (26.20) 361.00 (57.72) 347.49 (31.55)* 2.86 0.005 0.46 0.65 0.63 0.53
ERP, Event-related potential ; BP, bipolar disorder ; CC ill, concordant affected; DC ill, discordant affected; DC well, discordant unaffec-
ted; MMN, mismatch negativity.
* n=151.
Table 3. Maximum likelihood estimates of correlations between bipolar and ERP variables and
MZ/DZ twin correlations (and 95% CI)
ERP variables
Correlation of ERPs across twins Correlation with bipolar disorder across twins
Bipolar–ERP phenotypic
correlationMZ DZ MZ DZ
MMN amplitude 0.56 (0.35–0.71) 0.29 (x0.09 to 0.60) 0.22 (0.02–0.40) 0.30 (x0.46 to 0.76) 0.11 (x0.08 to 0.30)
P50 T/C ratio 0.63 (0.47–0.77) x0.17 (x0.52 to 0.14) 0.31 (0.11–0.49) 0.11 (x0.48 to 0.79) 0.24 (0.05–0.42)
P300 amplitude 0.79 (0.67–0.87) 0.34 (0.01–0.58) x0.27 (x0.46 tox0.08) x0.19 (x0.82 to 0.32) x0.33 (x0.51 tox0.12)
P300 latency 0.45 (0.26–0.62) 0.40 (0.02–0.63) 0.15 (x0.01 to 0.31) x0.15 (x0.36 to 0.69) 0.21 (x0.03 to 0.40)
ERP, event-related potential ; MZ, monozygotic ; DZ, dizygotic; CI, confidence interval ; MMN, mismatch negativity ; T/C ratio, test/
conditioning ratio.
The bipolar correlation is constrained to be 0.85 in MZ twins and 0.425 in DZ twins based on the point estimates, and 1% prevalence.
Intervals including 0 indicate non-significance.
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was associated with decreased P50 gating re-
sponses. Genetic correlation (rg=0.43–0.51),
significant across all three models, was the main
source for the phenotypic correlation; the en-
vironmental correlation (re) was non-significant.
Relationship between bipolar and P300
amplitude and latency
Across all three bipolar models, P300 amplitude
showed substantial heritability (h2=0.75–0.77,
95% CI 0.34–0.86) and significant individual
specific-environmental influence (e2=0.12, 95%
CI 0.01–0.25) with no shared environmental ef-
fect (c2=0.02) and low measurement error
(m2=0.11) (Table 4). P300 latency, on the con-
trary, showed relatively low heritability (h2=
0.21, 95% CI 0.02–0.62), significant only in
model 1. A significant familial effect was found
in models 2 and 3 but there was insufficient
power to distinguish genetic (A) and shared en-
vironmental (C) effects, such that both A and C
components could be dropped independently
but not simultaneously [Dx2 (df=2)=27.64,
p<0.0001].
A significant phenotypic correlation was
found between bipolar and P300 amplitude
(rph=x0.33 tox0.34, 95%CIx0.50 tox0.12,
Table 5) but not between bipolar and latency
(p>0.09), indicating that bipolar disorder was
associated with significantly smaller P300 am-
plitudes, not prolonged latencies.
Across all three bipolar models, shared genetic
factors are the main source of the phenotypic
correlations between bipolar disorder and am-
plitude, and the genetic correlation (rg) was
estimated to be between x0.33 and x0.35
(Table 5). Environmental correlations (re) were
non-significant.
DISCUSSION
Genetic analyses showed that all ERP measures,
with the exception of P300 latency, demon-
strated substantial heritability (h2) with no
evidence of shared environmental (c2) effects.
For P300 latency there was insufficient power
to distinguish genetic (A) and shared environ-
mental (C) effects.
The results of the present study revealed a
significant phenotypic relationship betweenP300
amplitude and bipolar disorder (x0.33), and
between P50 suppression and bipolar disorder
(0.24). Genetic factors (rg) were the main source
of these associations and were robust across
three sets of bipolar heritability values. Environ-
mental factors (re) were not significant. P300
latency and MMN amplitude, however, were
not associated with bipolar disorder.
Table 4. Additive genetic, common and specific environmental estimates (with 95% CI) of
full ACEM genetic models for each ERP index
h2 c2 e2 m2 Dx2 (df) p value
MMN amplitude
Model 1 0.55 (0.01–0.71) 0.01 (0–0.56) 0.27 (0.09–0.49) 0.17 (0.08–0.34) 15.80 (20) 0.73
Model 2 0.55 (0–0.71) 0.01 (0–0.56) 0.27 (0.09–0.49) 0.17 (0.08–0.35)
Model 3 0.54 (0–0.71) 0.01 (0–0.56) 0.27 (0.09–0.49) 0.17 (0.08–0.35)
P50 ratio
Model 1 0.57 (0.26–0.72) 0 (0–0.24) 0.24 (0.05–0.46) 0.19 (0.09–0.41) 25.49 (20) 0.18
Model 2 0.56 (0.26–0.72) 0 (0–0.24) 0.24 (0.05–0.46) 0.20 (0.09–0.41)
Model 3 0.56 (0.26–0.72) 0 (0–0.24) 0.24 (0.05–0.46) 0.20 (0.09–0.41)
P300 amplitude
Model 1 0.75 (0.36–0.85) 0.02 (0–0.37) 0.12 (0.01–0.25) 0.11 (0.05–0.23) 51.70 (37) 0.06
Model 2 0.77 (0.34–0.86) 0 (0–0.01) 0.12 (0.01–0.25) 0.11 (0.05–0.24)
Model 3 0.75 (0.35–0.86) 0.02 (0–0.38) 0.12 (0.01–0.25) 0.11 (0.05–0.23)
P300 latency
Model 1 0.21 (0.01–0.60) 0.26 (0–0.52) 0.27 (0.07–0.48) 0.26 (0.15–0.46) 51.70 (37) 0.06
Model 2 0.16 (0–0.61) 0.31 (0–0.52) 0.27 (0.07–0.49) 0.26 (0.15–0.46)
Model 3 0.17 (0–0.61) 0.31 (0–0.52) 0.27 (0.07–0.49) 0.26 (0.15–0.46)
ERP, Event-related potential ; CI, confidence interval ; MMN, mismatch negativity ; df, degrees of freedom; h2, c2, e2 and m2 are heritability,
shared environmental, non-shared environmental and measurement error estimates respectively.
CIs including zero indicate non-significance.
Fixed genetic models for bipolar disorder used: (1) h2=0.93, c2=0, e2=0.07 (2) h2=0.85, c2=0, e2=0.15 and (3) h2=0.73, c2=0, e2=0.27.
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For P50 suppression and P300 amplitude, the
mean analyses andmodel fitting analyses showed
contrasting results. There are two possible
explanations. One may be that model fitting
produced artificial genetic correlations between
bipolar disorder and P300 amplitude and
P50 ratio, perhaps because of model mis-
specification: (i) the heritability of bipolar dis-
order may have been fixed at too high a value
and (ii) the shared environmental component
was omitted in the model. First, significant
genetic correlations were found even for the
lowest heritability models for bipolar disorder
(75%), which is realistic given estimates re-
ported by other small population-based twin
studies (Kendler et al. 1993; Cardno et al. 1999).
Second, as no relevant meta-analysis is avail-
able, fixed parameters of heritability and family
environment in bipolar disorder were based on
the results of the largest published bipolar twin
study. This report found no significant shared
environment contribution to liability to the dis-
order. By constraining the familial environ-
mental effect for bipolar disorder to be zero, it is
not possible to estimate a shared environmental
correlation. It could be argued that our results
may have optimized the genetic correlation.
However, the MZ cross-trait cross-twin corre-
lations for P300 amplitude are about twice as
large as those of the DZ twins and more than
twice as large for the P50 ratio, suggesting that
shared environmental effects are unlikely to
contribute to the phenotypic correlations.
A second explanation may be that model
fitting is more powerful than analysis of means.
Mean comparisons do not use all available in-
formation and thus were unable to capture an
overall profile of the data, whereas the model
fitting analysis was able to detect a model that
can best describe the overall correlation patterns
in the dataset. We performed a mean scores
based simulation (F. Rijsdijk, unpublished data)
to explore the overall profiles of mean differ-
ences between groups (controls, concordant,
discordant affected and discordant unaffected
twins). These simulation results suggest that the
mean scores of both twins from concordant
pairs and unaffected co-twins of the discordant
twins are crucial in determining the overall
profiles of mean differences between groups,
while the mean scores of affected discordant
twins remain unchanged regardless of the nature
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of the correlation with the disorder. The present
study observed an impairment in the scores of
concordant twin pairs, an elevated score in the
well co-twin group (although non-significant)
and normal P50 scores in the discordant ill
twins. These results were most consistent with
the simulation results when genetic, but not en-
vironmental, correlation was present.
Several studies have found prolonged P300
latency in bipolar patients (Muir et al. 1991;
Souza et al. 1995; Strik et al. 1998; O’Donnell
et al. 2004). In the present study a significant
familial effect was found, but it was not possible
to distinguish between heritable and shared en-
vironment effects. The genetic contribution to
the observed correlation between latency and
bipolar disorder is a function of the two sets
of heritabilities that influence the traits, and of
the correlation between these two sets. The low
heritability of P300 latency means that the gen-
etic contribution to the observed correlation will
also be low. It is clear that, for the latency vari-
able, we do not have sufficient power to detect
small effects suggested by the results. Therefore,
it is possible that a relationship between P300
latency and bipolar disorder exists, that would
be detectable in a larger sample.
Consistent with reports of the case–control
and family studies, MMN was not associated
with the bipolar disorder : subjects with bipolar
disorder had normal MMN functioning. This
may reflect a relatively preserved neuronal
function and perhaps a normal genetic archi-
tecture related to MMN (Umbricht et al. 2003).
Patients from the concordant twin group
consistently showed severer deficits than patients
of the discordant twin group in both P300
and P50 paradigms, suggesting that there may
be differences in genetic liability between the
two groups; that is, concordant twin pairs may
have a greater genetic liability to the bipolar
disorder than discordant twin pairs (Markow &
Gottesman, 1989) and the extent of epigenetic
differences in MZ discordant may be greater
than in MZ concordant twin pairs (Petronis,
2003; Wong et al. 2005). Disease heterogeneity,
however, may be an alternative explanation.
The proportion of smokers was significantly
higher in the patient group than in unaffected
individuals. The number of cigarettes smoked
per day was significantly higher in patients
from concordant twin pairs who had the most
impaired suppression ratio. P50 suppression has
been associated with lower alpha-7 nicotinic re-
ceptor level in schizophrenics and their relatives
(Freedman et al. 1997). It is possible that these
concordant bipolar patients may have lower
levels of nicotine receptors, similar to schizo-
phrenic patients, and therefore smoke more
cigarettes to compensate for the deficit level of
nicotine receptors.
This study is subject to a number of limi-
tations. First, the sample size was small, par-
ticularly for the concordant bipolar twin pairs.
Second, disease parameters could not be based
on meta-analysis results. Third, we cannot
entirely rule out effects of medications in the
patients group. Patients received various psy-
chotropic medications at the time of the ERP
recording. However, there were no differences in
ERP responses between patients and their un-
affected, unmedicated co-twins, suggesting that
medication was unlikely to have contributed
significantly to the ERP differences observed in
our data. Fourth, the incidence of life-time di-
agnosis of major depression was significantly
higher in the unaffected co-twin of the dis-
cordant twin group (p=0.03) compared to con-
trols, suggesting an overlap in aetiology. The
current study was unable to assess the relation-
ship between major depression and mania.
However, McGuffin et al. (2003) reported that
‘although mania and depression are correlated
genetically, most of the genetic influence on
liability to mania is distinct from the genetic
liability to depression’.
In conclusion, we report the first ERP study
in twins with a diagnosis of bipolar disorder and
found significant genetic associations between
bipolar disorder and P300 amplitude and P50
suppression, suggesting that these two ERP
components are endophenotypes for bipolar
disorder. The identification of susceptibility
genes for complex disorders such as bipolar
disorder will require convergence in biological
evidence of the risk variant’s impacts on the
pathogenesis of the disease (Kendler, 2005). The
use of endophenotypes can help in two ways.
First, individual differences in liability of an
endophenotypic trait can be quantified on a
continuous scale, thus providing a significant
improvement in power to identification of
possible gene carriers. Second, endophenotypes
allow a disorder to be studied on a more
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elementary level and therefore may also help to
elucidate the pathophysiology of the disorders.
Hypotheses about biological deficits in bipolar
disorder could be studied further in animal
models, where invasive studies of specific neuro-
biological mechanisms such as receptors,
neurotransmitters and growth factors can be
performed (Freedman et al. 1999; de Geus,
2002; Gottesman & Gould, 2003; Gould &
Gottesman, 2006). In this way, the gap in our
knowledge between statistically significant gene
findings and the biological basis linking these
genes to the disorder can be remedied by in-
creased understanding of the biology, and the
results of the new biological investigations can
be supported by the findings from genetic
analysis.
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